MedTrace Logo

Thromboembolic And Bleeding Risks During anticoaGulant trEatment in Asian paTients With Atrial Fibrillation (TARGET-AF)

NCT06874894 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1021

Last updated 2025-12-29

No results posted yet for this study

Summary

This study was design to investigate the efficacy and safety of NOAC therapy in Koreans

Conditions

  • Fibrillation, Atrial

Sponsors & Collaborators

  • Chung-Ang University Gwangmyeong Hospital

    collaborator OTHER

  • Samsung Medical Center

    collaborator OTHER

  • Korea University Ansan Hospital

    collaborator OTHER

  • Kosin University Gospel Hospital

    collaborator OTHER

  • Keimyung University Dongsan Medical Center

    collaborator OTHER

  • Yuhan Corporation

    collaborator INDUSTRY

  • Chung-Ang University Hosptial, Chung-Ang University College of Medicine

    lead OTHER

Eligibility

Min Age
18 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-25
Primary Completion
2026-08-30
Completion
2026-08-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06874894 on ClinicalTrials.gov